Physician profile
Casey E Nolan
NPI 1548931041
$1,029.18
in general payments reported to CMS, 2019-2025
8 companies · $683 in 2025
The $683 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $150 · 2024: $197 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $268.18 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $232.73 | 2024-2025 | Amvuttra |
| Pfizer INC. | $156.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $108.23 | 2025 | |
| Amgen INC. | $99.51 | 2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.09 | 2025 | Jardiance |
| Scpharmaceuticals INC. | $51.57 | 2024 | |
| Lantheus Medical Imaging, INC. | $23.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.